“The existing situation has exposed some structural weaknesses inside the EU’s medicines source chain in addition to a significant dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides stated. She advised that provide chain troubles be resolved within an EU pharmaceutical t